Product Images Tamsulosin Hydrochloride
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 9 images provide visual information about the product associated with Tamsulosin Hydrochloride NDC 68084-299 by American Health Packaging, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Tamsulosin Hydrochloride is a medication used in the treatment of symptoms associated with an enlarged prostate gland. The medication's strength ranges from 0.4 mg to 4 mg.*
This is a medication called Tamsulosin Hydrochloride. It comes in the form of capsules and is available in a bottle containing 100 capsules. The usual dosage instructions are included in a package insert. Store this medication at 20° to 25°C (68" to 77°F), with permitted excursions between 15° to 30°C (59" to 86°F) [see USP Controlled Room Temperature]. The medication should be kept out of reach of children. The drug product is from NDC # 68382-132, Zydus Pharmaceuticals USA Inc. It is distributed by American Health Packaging in Columbus, Ohio.*
This is a table showing the mean change in treatment over different weeks for a group of patients. The treatment involved a combination of different doses of medication and a placebo group. The number of patients in each group also varies across different weeks. There is no available information regarding the actual medication or medical condition being treated.*
This appears to be a table with headings "Mean Change" and "Treatment". The treatment column has three values: "-0-0-0-08mg", "A A-A-0.4 mg", and "Placebo". The table also has several rows with dashes and "T" characters, and numbers from 1 to 13 and "LOCF". It is not clear what these rows represent. The last row shows the duration of treatment in weeks. It is not possible to determine the context or purpose of this table from this text alone.*
This appears to be a table showing the mean change in treatment for a particular duration of treatment (in weeks), with three different treatment types (0.08mg, 0.4mg, and placebo). The table also includes LOCF (last observation carried forward) data for weeks 4, 7, 10, and 13. However, some characters are unreadable and cannot be interpreted.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.